These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1665585)

  • 1. Urokinase-dependent proteolysis in cultured colon cancer is directed by its receptor.
    Hollas W; Boyd D
    Semin Thromb Hemost; 1991 Jul; 17(3):225-30. PubMed ID: 1665585
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of the urokinase receptor in facilitating extracellular matrix invasion by cultured colon cancer.
    Hollas W; Blasi F; Boyd D
    Cancer Res; 1991 Jul; 51(14):3690-5. PubMed ID: 1648443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of the role of the urokinase receptor in human colon cancer mediated laminin degradation.
    Schlechte W; Murano G; Boyd D
    Cancer Res; 1989 Nov; 49(21):6064-9. PubMed ID: 2551498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasion of extracellular matrix by cultured colon cancer cells: dependence on urokinase receptor display.
    Schlechte W; Brattain M; Boyd D
    Cancer Commun; 1990; 2(5):173-9. PubMed ID: 2164413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of urokinase on cell proliferation and invasion.
    Binder BR
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):717-20. PubMed ID: 1966799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cancer cell urokinase plasminogen activator by its specific inhibitor PAI-2 and subsequent effects on extracellular matrix degradation.
    Baker MS; Bleakley P; Woodrow GC; Doe WF
    Cancer Res; 1990 Aug; 50(15):4676-84. PubMed ID: 2114945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous receptor-bound urokinase mediates tissue invasion of the human lung carcinoma cell lines A549 and Calu-1.
    Bruckner A; Filderman AE; Kirchheimer JC; Binder BR; Remold HG
    Cancer Res; 1992 Jun; 52(11):3043-7. PubMed ID: 1375533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the effects of epidermal growth factor on urokinase secretion and urokinase receptor display in a well-differentiated human colon carcinoma cell line.
    Boyd D; Brattain M
    Cancer Res; 1989 Apr; 49(8):1948-53. PubMed ID: 2539250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insensitivity of laminin degradation directed by receptor bound urokinase to PAI-1 in cultured colon cancer.
    Schlechte JW; Boyd DD
    Cancer Commun; 1990; 2(8):261-9. PubMed ID: 2390419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the plasminogen activation system in kidney cancer correlates with its aggressive phenotype.
    Swiercz R; Wolfe JD; Zaher A; Jankun J
    Clin Cancer Res; 1998 Apr; 4(4):869-77. PubMed ID: 9563880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laminin degradation by human colon carcinoma cells: a role for urinary and tissue plasminogen activators.
    Sordat BC; Tran-Thang C
    Invasion Metastasis; 1994-1995; 14(1-6):223-33. PubMed ID: 7657515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Co115 colon carcinoma cells potentiate the degradation of laminin mediated by tissue-type plasminogen activator.
    Tran-Thang C; Vouillamoz D; Kruithof EK; Sordat B
    J Cell Physiol; 1994 Nov; 161(2):285-92. PubMed ID: 7962113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas.
    Pyke C; Kristensen P; Ralfkiaer E; Grøndahl-Hansen J; Eriksen J; Blasi F; Danø K
    Am J Pathol; 1991 May; 138(5):1059-67. PubMed ID: 1850957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. uPA and uPAR contribute to NK cell invasion through the extracellular matrix.
    Al-Atrash G; Kitson RP; Xue Y; Mazar AP; Kim MH; Goldfarb RH
    Anticancer Res; 2001; 21(3B):1697-704. PubMed ID: 11497249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examination of the effects of epidermal growth factor on the production of urokinase and the expression of the plasminogen activator receptor in a human colon cancer cell line.
    Boyd D
    Cancer Res; 1989 May; 49(9):2427-32. PubMed ID: 2539903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of the levels of urokinase and its receptor in human colon carcinoma cell lines.
    Boyd D; Florent G; Kim P; Brattain M
    Cancer Res; 1988 Jun; 48(11):3112-6. PubMed ID: 2835152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of urokinase plasminogen activator receptor in thrombospondin 1-mediated tumor cell invasion.
    Albo D; Berger DH; Rothman VL; Tuszynski GP
    J Surg Res; 1999 Apr; 82(2):331-8. PubMed ID: 10090848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen binding and activation at the breast cancer cell surface: the integral role of urokinase activity.
    Stillfried GE; Saunders DN; Ranson M
    Breast Cancer Res; 2007; 9(1):R14. PubMed ID: 17257442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urokinase-type plasminogen activator receptors associate with beta1 and beta3 integrins of fibrosarcoma cells: dependence on extracellular matrix components.
    Xue W; Mizukami I; Todd RF; Petty HR
    Cancer Res; 1997 May; 57(9):1682-9. PubMed ID: 9135008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells.
    Rosenthal EL; Johnson TM; Allen ED; Apel IJ; Punturieri A; Weiss SJ
    Cancer Res; 1998 Nov; 58(22):5221-30. PubMed ID: 9823336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.